Showing results (401-410 of 474) with videos related to
Sort By:
Pageof 48
Health Technology Assessment (Winchester, England)|September 25, 2020
Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCTRichard Gilson, Diarmuid Nugent, Kate Bennett, et al.Plos Medicine|October 4, 2021
COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectivenessCarl A B Pearson, Fiammetta Bozzani, Simon R Procter, et al.Gates Open Research|October 14, 2024
Estimating the impact of vaccination: lessons learned in the first phase of the Vaccine Impact Modelling ConsortiumKaty A M Gaythorpe, Xiang Li, Hannah Clapham, et al.International Journal of Epidemiology|February 9, 2024
Effects of sequential vs single pneumococcal vaccination on cardiovascular diseases among older adults: a population-based cohort studyXinning Tong, Le Gao, Ian C K Wong, et al.BMC Infectious Diseases|December 1, 2024
How mathematical modelling can inform outbreak response vaccinationManjari Shankar, Anna-Maria Hartner, Callum R K Arnold, et al.Lancet Regional Health. Americas|July 6, 2022
Effectiveness of CoronaVac and BNT162b2 COVID-19 mass vaccination in Colombia: A population-based cohort studyAngel Paternina-Caicedo, Mark Jit, Nelson Alvis-Guzmán, et al.Plos Medicine|February 20, 2026
The potential impact of reduced international donor funding on the household economic burden of tuberculosis in low- and middle-income countries: A modeling studyAllison Portnoy, Rebecca A Clark, Mark Jit, et al.BMC Medicine|March 7, 2023
Assessing the impacts of COVID-19 vaccination programme's timing and speed on health benefits, cost-effectiveness, and relative affordability in 27 African countriesYang Liu, Simon R Procter, Carl A B Pearson, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 10, 2021
The CAPACITI Decision-Support Tool for National Immunization ProgramsSiobhan Botwright, Birgitte K Giersing, Martin I Meltzer, et al.Vaccines|August 26, 2023
Population-Level Risk Factors Related to Measles Case Fatality: A Conceptual Framework Based on Expert Consultation and Literature ReviewAlyssa N Sbarra, Mark Jit, Jonathan F Mosser, et al.Pageof 48